Search

Search Results
Results 171 - 180 of 503 for breast cancer
  • Drug - 21 Jun 2019
    Consumer Medicine Information (CMI) about Giotrif (afatinib) intended for persons living in Australia.
  • Drug - 13 Oct 2025
    Consumer Medicine Information (CMI) about CellCept intended for persons living in Australia.
  • Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about DBL Dexamethasone Sodium Phosphate (Dexamethasone Phosphate) intended for persons living in Australia.
  • Drug - 6 Aug 2025
    Consumer Medicine Information (CMI) about Abrilada intended for persons living in Australia.
  • Drug - 25 Feb 2025
    Consumer Medicine Information (CMI) about Xeljanz intended for persons living in Australia.
  • Drug - 24 Apr 2024
    Consumer Medicine Information (CMI) about Lenalidomide Viatris intended for persons living in Australia.
  • Drug - 3 Apr 2024
    Consumer Medicine Information (CMI) about Piax Plus Asprin (clopidogrel hydrogen sulfate and aspirin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Cytarabine (Cytarabine) intended for persons living in Australia.
  • Drug - 5 Jan 2023
    Consumer Medicine Information (CMI) about Salpraz Heartburn Relief (reformulation 2) (Pantoprazole enteric coated tablets) intended for persons living in Australia.
  • Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about Somac Heartburn Relief (pantoprazole sodium sesquihydrate) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.